Propanc Biopharma, Inc. (PPCB) financial statements (2022 and earlier)

Company profile

Business Address 302/6 BUTLER STREET
CAMBERWELL, VICTORIA, 3124
State of Incorp. DE
Fiscal Year End June 30
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

12/31/2021
TTM
6/30/2021
6/30/2020
6/30/2019
6/30/2018
6/30/2017
6/30/2016
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments7426722069121
Cash and cash equivalents7426722069121
Receivables64256832
Other undisclosed current assets6  83355210
Total current assets:85769916182363
Noncurrent Assets
Operating lease, right-of-use asset  22
Property, plant and equipment346881113
Long-term investments and receivables   2222
Due from related parties   2222
Deposits noncurrent assets222    
Deferred costs20      
Other undisclosed noncurrent assets      2
Total noncurrent assets:2572911101316
TOTAL ASSETS:11013991027195379
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:1,3391,4211,196723364477137
Accounts payable9211,0028429171,157484370
Employee-related liabilities41941935432414312193
Other undisclosed accounts payable and accrued liabilities   (518)(936)(127)(326)
Debt9736251,5581,6574,6993,4821,205
Deferred compensation liability22254177698372877994
Derivative instruments and hedges, liabilities     456
Due to related parties32333131333534
Other undisclosed current liabilities4749487781,2931,355661518
Total current liabilities:3,0403,0813,7404,4036,8235,5372,944
Noncurrent Liabilities
Total liabilities:3,0403,0813,7404,4036,8235,5372,944
Stockholders' equity
Stockholders' equity attributable to parent, including:(2,930)(3,068)(3,641)(4,301)(6,752)(5,442)(2,565)
Common stock53142581465729
Treasury stock, value(46)(46)(46)(46)(46)(46) 
Additional paid in capital55,61554,07450,65645,71338,16832,98026,946
Accumulated other comprehensive income (loss)1,1421,0851,2681,067358(142)131
Accumulated deficit(59,698)(58,199)(55,782)(51,041)(45,283)(38,244)(30,376)
Other undisclosed stockholders' equity attributable to parent5555555
Total stockholders' equity:(2,930)(3,068)(3,641)(4,301)(6,752)(5,442)(2,565)
TOTAL LIABILITIES AND EQUITY:11013991027195379

Income statement (P&L) ($ in thousands)

12/31/2021
TTM
6/30/2021
6/30/2020
6/30/2019
6/30/2018
6/30/2017
6/30/2016
Gross profit:   (28)(31)(29)(25)
Operating expenses(2,044)(1,812)(3,494)(2,615)(3,960)(5,740)(6,898)
Other undisclosed operating income   28312925
Operating loss:(2,044)(1,812)(3,494)(2,615)(3,960)(5,740)(6,898)
Nonoperating expense(612)(327)(1,381)(3,950)(3,259)(2,433)(2,585)
Foreign currency transaction loss, before tax(16)  (691)   
Other nonoperating expense  (1,381)(3,259)(3,259)(2,433)(2,585)
Interest and debt expense(287)51671,204251(196)(671)
Loss from continuing operations before equity method investments, income taxes:(2,943)(2,089)(4,808)(5,360)(6,967)(8,369)(10,154)
Other undisclosed loss from continuing operations before income taxes(51)(51) (398)   
Loss from continuing operations before income taxes:(2,994)(2,139)(4,808)(5,758)(6,967)(8,369)(10,154)
Income tax benefit16911313511517930673
Loss before gain (loss) on sale of properties:(2,825)(2,026)(4,674)(5,643)(6,788)(8,063)(10,081)
Other undisclosed net income110      
Net loss:(2,715)(2,026)(4,674)(5,643)(6,788)(8,063)(10,081)
Other undisclosed net income (loss) attributable to parent(279)(392)(67)(115)(251)196671
Net loss attributable to parent:(2,994)(2,418)(4,741)(5,758)(7,039)(7,868)(9,410)
Preferred stock dividends and other adjustments(93)      
Net loss available to common stockholders, diluted:(3,087)(2,418)(4,741)(5,758)(7,039)(7,868)(9,410)

Comprehensive Income ($ in thousands)

12/31/2021
TTM
6/30/2021
6/30/2020
6/30/2019
6/30/2018
6/30/2017
6/30/2016
Net loss:(2,715)(2,026)(4,674)(5,643)(6,788)(8,063)(10,081)
Other comprehensive income64182     
Other undisclosed comprehensive income182      
Comprehensive loss:(2,469)(1,843)(4,674)(5,643)(6,788)(8,063)(10,081)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent(501)(757)134594248(77)701
Comprehensive loss, net of tax, attributable to parent:(2,970)(2,600)(4,540)(5,049)(6,539)(8,141)(9,380)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: